Galmed Pharmaceutica...
NasdaqCM:GLMD
$ 0,74
$-0,05 (-6,33%)
0,74 $
$-0,05 (-6,33%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$0,00
Earnings Per Share
$0,00
Revenue Per Share
0,00%
Gross Margin %
$0,01 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$0,00
Revenue Per Share
$0,00
Gross Margin %
0,00%
Market Cap
$0,01 B
Long-Term Debt
$0,00 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
EPS Earnings Per Share $-8,08 $-30,00 $-127,80 $-237,60 $-243,00 $-174,60 $-97,20 $-176,40 $-268,20 $-172,80 $-158,40
Earnings Earnings $-18,26M $-15,00M $-17,89M $-33,26M $-34,02M $-20,95M $-11,66M $-14,11M $-18,77M $-10,37M $-9,50M
RPS Revenue Per Share $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $17,00 $13,63 $6,71 $0,00 $0,00
Revenue Revenue $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $2,04M $1,09M $0,47M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $0,00M $-18,50M $0,00M $-26,29M $-14,94M $-9,02M $-12,07M $-12,13M $0,00M $0,00M
FCF Free Cash Flow $0,00M $0,00M $0,00M $0,00M $-26,33M $-14,95M $-11,62M $-12,08M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 100,00% 100,00% 100,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $-6,32 $-26,59 $-132,48 $-240,78 $-222,72 $-127,44 $-90,44 $-174,11 $-192,20 $-139,99 $-174,55
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 2,26M 0,5M 0,14M 0,14M 0,14M 0,12M 0,12M 0,08M 0,07M 0,06M 0,06M
×